AUTOLYSIS PARALLELS ACTIVATION OF MU-CALPAIN

Citation
A. Baki et al., AUTOLYSIS PARALLELS ACTIVATION OF MU-CALPAIN, Biochemical journal, 318, 1996, pp. 897-901
Citations number
35
Categorie Soggetti
Biology
Journal title
ISSN journal
02646021
Volume
318
Year of publication
1996
Part
3
Pages
897 - 901
Database
ISI
SICI code
0264-6021(1996)318:<897:APAOM>2.0.ZU;2-#
Abstract
The kinetics of autolysis and activation of mu-calpain were measured w ith microtubule-associated protein 2 (MAP2) as a very sensitive substr ate. The initial rate of MAP2 hydrolysis was found to be a linear func tion of the autolysed 76 kDa form of mu-calpain large subunit at both 10 and 300 mu M Ca2+, and both straight lines intersected the origin. This finding supports the view that native mu-calpain is an inactive p roenzyme and that activation is accompanied by autolysis. The host-ord er rate constant of autolysis, k(I)(aut), was determined at different Ca2+ concentrations: the half-maximal value was at pCa(2+) = 3.7 (197 mu M Ca2+), whereas the maximal value was 1.52 s(-1), at 30 degrees C. The Ca2+-induced activation process was then monitored by using our n ovel, continuous fluorimetric assay with labelled MAP2 as substrate. T he first-order rate constant of activation, k(I)(act), was derived as the reciprocal of the lag phase ('transit time') at the initial part o f the progress curve: half-maximum was at pCa(2+) = 3.8 (158 mu M Ca2) and the maximum value was 2.15 s(-1). The good agreement between the kinetic parameters of mu-calpain autolysis and activation is remarkab le. We claim that this is the first kinetically correct determination of the rate constant of autolysis of mu-calpain. Pre-activated mu-calp ain has a Ca2+ requirement that is almost three orders of magnitude sm aller [half-maximal activation at pCa(2+) = 6.22 (0.6 mu M Ca2+)]. We cannot exclude the possibility that the activation process involves ot her mechanistic steps, e.g. the rapid dissociation of the p-calpain he terodimer, but we state that in our conditions in vitro autolysis and activation run in close parallel.